---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-238127"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2023-09-20T23:59:59+00:00"
generated_at: "2026-06-10T12:17:12.651232+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tivic Health regains Nasdaq compliance after reverse split; delisting averted

## Summary
- Nasdaq notified Tivic on Sept 15, 2023 that bid price deficiency is cured.
- Company effected 1-for-100 reverse stock split on Aug 21, 2023 to cure deficiency.
- Nasdaq cancelled the hearing and reversed its delisting determination.
- Common stock continues trading on Nasdaq Capital Market under TIVC.
- No financial impact disclosed beyond compliance status.

## SEC filing metadata
- accession: 0001193125-23-238127
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2023-09-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000119312523238127/0001193125-23-238127-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000119312523238127/d556941d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-238127
- JSON: https://secwatch.observer/filing/0001193125-23-238127.json
- Plain text: https://secwatch.observer/filing/0001193125-23-238127.txt

## Key facts
- Listing & Compliance Notices
  Valion Bio, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: compliance regained
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: September 15, 2023, Nasdaq notified the Company that the Company’s bid price deficiency has been cured and that the Company is in compliance with all applicable listing standards. As a result, Nasdaq has cancelled the Hearing, reversed its delisting determination and confirmed that the Company’s common stock will continue to be listed and traded on the Nasdaq Capital Market under the symbol “TIVC.”
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000119312523238127/0001193125-23-238127-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.